Arthur Taveras

Insider Reports History

Location
Boston, MA
Signature
/s/ Adam S. Mostafa, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arthur Taveras:

Company Role Class Num Shares Value Price $ Report Date Ownership
X4 Pharmaceuticals, Inc Chief Scientific Officer Common Stock 388,026 $218,459 $0.5630 07 Oct 2024 Direct
X4 Pharmaceuticals, Inc Chief Scientific Officer Stock Appreciation Right 428,248 13 Feb 2024 Direct

Insider Reports Filed by Arthur Taveras

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XFOR X4 Pharmaceuticals, Inc 04 Oct 2024 2 -$43,306 4 Chief Scientific Officer 08 Oct 2024, 16:44
XFOR X4 Pharmaceuticals, Inc 11 Mar 2024 1 -$12,552 4 Chief Scientific Officer 11 Mar 2024, 17:20
XFOR X4 Pharmaceuticals, Inc 13 Feb 2024 1 $0 4 Chief Scientific Officer 16 Feb 2024, 17:08
XFOR X4 Pharmaceuticals, Inc 12 Feb 2024 1 -$793 4 Chief Scientific Officer 12 Feb 2024, 17:23
XFOR X4 Pharmaceuticals, Inc 01 Nov 2023 1 -$49,417 4 Chief Scientific Officer 03 Nov 2023, 16:39
XFOR X4 Pharmaceuticals, Inc 31 Oct 2023 1 $0 4 Chief Scientific Officer 02 Nov 2023, 16:59
XFOR X4 Pharmaceuticals, Inc 10 Mar 2023 1 -$14,117 4 Chief Scientific Officer 13 Mar 2023, 16:48
XFOR X4 Pharmaceuticals, Inc 13 Feb 2023 1 -$863 4 Chief Scientific Officer 15 Feb 2023, 16:13
XFOR X4 Pharmaceuticals, Inc 07 Nov 2022 1 $0 4 Chief Scientific Officer 09 Nov 2022, 15:22
XFOR X4 Pharmaceuticals, Inc 01 Mar 2022 1 $0 4 Chief Scientific Officer 01 Mar 2022, 15:09
XFOR X4 Pharmaceuticals, Inc 11 Feb 2022 1 $0 4 Chief Scientific Officer 14 Feb 2022, 15:21